Ubs Group Ag Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Ubs Group Ag

  • $400 Billion
  • Q2 2024

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022
BUY
$144.95 - $152.29 $81.1 Million - $85.2 Million
559,438 Added 204.16%
833,464 $126 Million
Q2 2022

Aug 10, 2022
BUY
$83.14 - $145.99 $19.7 Million - $34.5 Million
236,397 Added 628.23%
274,026 $39.9 Million
Q1 2022

May 16, 2022
BUY
$110.08 - $142.92 $2.85 Million - $3.7 Million
25,883 Added 220.36%
37,629 $4.46 Million
Q4 2021

Feb 14, 2022
BUY
$99.73 - $148.48 $568,560 - $846,484
5,701 Added 94.31%
11,746 $1.62 Million
Q3 2021

Nov 15, 2021
BUY
$98.85 - $138.91 $148,868 - $209,198
1,506 Added 33.18%
6,045 $839,000
Q2 2021

Aug 13, 2021
SELL
$65.78 - $105.02 $2.29 Million - $3.66 Million
-34,821 Reduced 88.47%
4,539 $441,000
Q1 2021

May 12, 2021
BUY
$64.07 - $91.75 $1.16 Million - $1.66 Million
18,100 Added 85.14%
39,360 $2.69 Million
Q4 2020

Feb 11, 2021
BUY
$65.07 - $98.24 $1.29 Million - $1.94 Million
19,757 Added 1314.5%
21,260 $1.82 Million
Q3 2020

Nov 12, 2020
SELL
$59.04 - $77.95 $25,977 - $34,298
-440 Reduced 22.65%
1,503 $98,000
Q2 2020

Jul 31, 2020
BUY
$29.01 - $74.23 $23,062 - $59,012
795 Added 69.25%
1,943 $142,000
Q1 2020

May 01, 2020
BUY
$27.51 - $57.29 $4,511 - $9,395
164 Added 16.67%
1,148 $39,000
Q4 2019

Feb 14, 2020
SELL
$40.86 - $57.65 $4.15 Million - $5.85 Million
-101,495 Reduced 99.04%
984 $54,000
Q3 2019

Nov 14, 2019
BUY
$37.38 - $49.47 $3.57 Million - $4.73 Million
95,576 Added 1384.56%
102,479 $4.28 Million
Q2 2019

Aug 14, 2019
BUY
$39.79 - $67.01 $108,467 - $182,669
2,726 Added 65.26%
6,903 $302,000
Q1 2019

May 14, 2019
SELL
$34.52 - $53.29 $293,454 - $453,018
-8,501 Reduced 67.05%
4,177 $215,000
Q4 2018

Feb 14, 2019
SELL
$29.75 - $42.9 $39,954 - $57,614
-1,343 Reduced 9.58%
12,678 $469,000
Q3 2018

Nov 14, 2018
BUY
$32.79 - $43.0 $349,574 - $458,423
10,661 Added 317.29%
14,021 $527,000
Q2 2018

Aug 14, 2018
BUY
$23.62 - $42.29 $24,706 - $44,235
1,046 Added 45.2%
3,360 $133,000
Q1 2018

May 15, 2018
SELL
$22.49 - $34.56 $5,510 - $8,467
-245 Reduced 9.57%
2,314 $60,000
Q4 2017

Feb 14, 2018
BUY
$20.44 - $35.56 $44,763 - $77,876
2,190 Added 593.5%
2,559 $69,000
Q3 2017

Nov 14, 2017
BUY
$23.54 - $38.21 $8,686 - $14,099
369
369 $14,000

Others Institutions Holding BHVN

# of Institutions
11
Shares Held
785K
Call Options Held
0
Put Options Held
0
View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

BHVN Quotes by TradingView
  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $3.65B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email